Claims
- 1. A method for averting weight gain, comprising administering to a subject prone to weight gain an effective weight gain preventative amount of a biologically active .DELTA.5 Androstene-3.beta.-carboxylate-17-one steroid wherein the carboxylate is an ester of a saturated, unbranched C.sub.2-24 monocarboxylic acid.
- 2. A method for promoting weight loss, comprising administering to a subject in need of such treatment an effective weight reduction promoting amount of a biologically active .DELTA.5 Androstene-3.beta.-carboxylate-17-one steroid wherein the carboxylate is an ester of a saturated, unbranched C.sub.2-24 monocarboxylic acid.
- 3. A method of treating obesity, comprising administering to an obese subject a therapeutic amount of a biologically active .DELTA.5 Androstene-3.beta.-carboxylate-17-one steroid wherein the carboxylate is an ester of a saturated, unbranched C.sub.2-24 monocarboxylic.
- 4. The method of claim 1 wherein the saturated, unbranched C.sub.2-24 carboxylic acids are saturated, unbranched, short-chain fatty acids.
- 5. The method of claim 1 wherein the saturated, unbranched C.sub.2-24 carboxylic acids are saturated, unbranched, long-chain fatty acids.
- 6. The method of claim 2 wherein the saturated, unbranched C.sub.2-24 carboxylic acids are saturated, unbranched, short-chain fatty acids.
- 7. The method of claim 2 wherein the saturated, unbranched C.sub.2-24 carboxylic acids are saturated, unbranched, long-chain fatty acids.
- 8. The method of claim 3 wherein the saturated, unbranched C.sub.2-24 carboxylic acids are saturated, unbranched, short-chain fatty acids.
- 9. The method of claim 3 wherein the saturated, unbranched C.sub.2-24 carboxylic acids are saturated, unbranched, long-chain fatty acids.
- 10. A method for averting weight gain, comprising administering to a subject prone to weight gain an effective weight gain preventative amount of .DELTA.5 Androstene-3.beta.-hemisuccinate-17-one.
- 11. A method for promoting weight loss, comprising administering to a subject in need of such treatment an effective weight reduction promoting amount of .DELTA.5 Androstene-3.beta.-hemisuccinate-17-one.
- 12. A method of treating obesity, comprising administering to an obese subject a therapeutic amount of .DELTA.5 Androstene-3.beta.-hemisuccinate-17-one.
- 13. The method of claim 10 wherein the administration of .DELTA.5 Androstene-3.beta.-hemisuccinate-17-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.- hemisuccinate-17-one.
- 14. The method of claim 11 wherein the administration of .DELTA.5 Androstene-3.beta.-hemisuccinate-17-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.- hemisuccinate- 17-one.
- 15. The method of claim 12 wherein the administration of .DELTA.5 Androstene-3.beta.-hemisuccinate-17-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-hemisuccinate-17-one.
- 16. A method for averting weight gain, comprising administering to a subject prone to weight gain an effective weight gain preventative amount of .DELTA.5 Androstene-3.beta.-propionate-17- one.
- 17. A method for promoting weight loss, comprising administering to a subject in need of such treatment an effective weight reduction promoting amount .DELTA.5 Androstene-3.beta.- propionate-17-one.
- 18. A method of treating obesity, comprising administering to an obese subject a therapeutic amount of .DELTA.5 Androstene-3.beta.-propionate-17-one.
- 19. The method of claim 16 wherein the administration of .DELTA.5 Androstene-3.beta.-propionate-17- one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-propionate-17- one.
- 20. The method of claim 17 wherein the administration of .DELTA.5 Androstene-3.beta.-propionate-17- one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-propionate-17- one.
- 21. The method of claim 18 wherein the administration of .DELTA.5 Androstene-3.beta.-propionate-17- one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-propionate-17- one.
- 22. A method for averting weight gain, comprising administering to a subject prone to weight gain an effective weight gain preventative amount of .DELTA.5 Androstene-3.beta.-butyrate-17-one.
- 23. A method for promoting weight loss, comprising administering to a subject in need of such treatment an effective weight reduction promoting amount .DELTA.5 Androstene-3.beta.- butyrate-17-one.
- 24. A method of treating obesity, comprising administering to an obese subject a therapeutic amount of .DELTA.5 Androstene-3.beta.-butyrate-17-one.
- 25. The method of claim 22 wherein the administration of .DELTA.5 Androstene-3.beta.-butyrate-17-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-butyrate-17-one.
- 26. The method of claim 23 wherein the administration of .DELTA.5 Androstene-3.beta.-butyrate-17-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-butyrate-17-one.
- 27. The method of claim 24 wherein the administration of .DELTA.5 Androstene-3.beta.-butyrate-17-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-butyrate-17-one.
- 28. A method for averting weight gain, comprising administering to a subject prone to weight gain an effective weight gain preventative amount of .DELTA.5 Androstene-3.beta.-laurate-1 7-one.
- 29. A method for promoting weight loss, comprising administering to a subject in need of such treatment an effective weight reduction promoting amount .DELTA.5 Androstene-3.beta.-laurate-17-one.
- 30. A method of treating obesity, comprising administering to an obese subject a therapeutic amount of .DELTA.5 Androstene-3.beta.-laurate-17-one.
- 31. The method of claim 28 wherein the administration of .DELTA.5 Androstene-3.beta.-laurate-17-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-laurate-17-one.
- 32. The method of claim 29 wherein the administration of .DELTA.5 Androstene-3.beta.-laurate-17-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-laurate-17-one.
- 33. The method of claim 30 wherein the administration of .DELTA.5 Androstene-3.beta.-laurate-17-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-laurate-17-one.
- 34. A method for averting weight gain, comprising administering to a subject prone to weight gain an effective weight gain preventative amount of .DELTA.5 Androstene-3.beta.-palmitate-7-one.
- 35. A method for promoting weight loss, comprising administering to a subject in need of such treatment an effective weight reduction promoting amount .DELTA.5 Androstene-3.beta.-palmitate-7-one.
- 36. A method of treating obesity, comprising administering to an obese subject a therapeutic amount of .DELTA.5 Androstene-3.beta.-palmitate-7-one.
- 37. The method of claim 34 wherein the administration of .DELTA.5 Androstene-3.beta.-palmitate-7-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-palmitate-7-one.
- 38. The method of claim 35 wherein the administration of .DELTA.5 Androstene-3.beta.-palmitate-7-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-palmitate-7-one.
- 39. The method of claim 36 wherein the administration of .DELTA.5 Androstene-3.beta.-palmitate-7-one comprises the administration of substantially pure .DELTA.5 Androstene-3.beta.-palmitate-7-one.
Parent Case Info
This application is a continuation-in-part of U.S. patent application Ser. No. 08/189,917 filed 2, Feb. 1994, U.S. Pat. No. 5,585,371 issued 17 Dec. 1996, which is a continuation-in-part of U.S. patent application Ser. No. 07/922,850 filed 31 Jul. 1992, now issued as U.S. Pat. No. 5,292,730, which is a continuation-in-part of U.S. patent application Ser. No. 07/867,288 filed 10 Apr. 1992, now issued as U.S. Pat. No. 5,296,481, which is a continuation of U.S. patent application Ser. No. 07/575,156 filed 29 Aug. 1990, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
5296481 |
Partridge et al. |
Mar 1994 |
|
5585371 |
Lardy |
Dec 1996 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
575156 |
Aug 1990 |
|
Continuation in Parts (3)
|
Number |
Date |
Country |
Parent |
189917 |
Feb 1994 |
|
Parent |
922850 |
Jul 1992 |
|
Parent |
867288 |
Apr 1992 |
|